Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06931561 · ClinicalTrials.gov registry record · NA

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

A NA study of Cancer, sponsored by Inova Health Care Services.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT06931561: Recruiting NA study of Cancer, sponsored by Inova Health Care Services.

NCT06931561 is a NA study of Cancer that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 800 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06931561, a NA study of Cancer, is actively recruiting participants, sponsored by Inova Health Care Services.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters. This study involves an investigational test (cancer blood test) that has not been approved by the U.S. Food and Drug Administration (FDA). Whole-body MRI and whole-body ultrasound are approved by the U.S. Food and Drug Administration (FDA) to be used in the diagnosis of some cancers and is approved for adults and children who present other signs of potential disease. In this study, however, the whole-body MRI and the whole-body ultrasound are considered investigational devices because they are not yet approved for use in healthy adults with no other cancer indications.

Primary Outcome

The number of confirmed pre-malignancies detected using whole-body Magnetic Resonance Imaging (MRI), whole-body ultrasound, or the Multi Cancer Detection (MCD) test

Conditions Studied

Interventions

  • PROCEDURE Whole Body MRI
  • PROCEDURE Whole Body Ultrasound
  • DEVICE MCD Assay
  • OTHER Occupational Exposure Questionnaire

Study Locations (1)

Virginia

  • Inova Schar Cancer - Saville Cancer Screening and Prevention Center - Fairfax

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2025-02-11
Est. Completion 2028-09-30
Phase NA
Inova Health Care Services

75 total trials

What NCT06931561 shows while recruiting

NCT06931561 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Whole Body MRI is the first listed.

NCT06931561 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06931561 about?

NCT06931561 is a clinical study titled "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System". The purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters. This study involves an investigational test...

What is the current status of trial NCT06931561?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-02-11. Estimated completion is 2028-09-30.

What conditions does trial NCT06931561 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06931561?

The interventions under investigation include: Whole Body MRI (PROCEDURE), Whole Body Ultrasound (PROCEDURE), MCD Assay (DEVICE), Occupational Exposure Questionnaire (OTHER).

Who is sponsoring clinical trial NCT06931561?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06931561 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06931561's enrollment target sits among peer trials

800 94th of 615 higher than 521 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06931561, the US trial registry maintained by the National Library of Medicine. NCT06931561 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.